• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
FDA

What’s Actually in Your Dietary Supplements? Maybe Drugs, Study Says

By
Brittany Shoot
Brittany Shoot
Down Arrow Button Icon
By
Brittany Shoot
Brittany Shoot
Down Arrow Button Icon
October 12, 2018, 7:21 PM ET
Video Poster

n wide-ranging analysis, researchers studying dietary supplements that had been submitted to the U.S. Food and Drug Administration (FDA) found that the little pills could be big trouble. Many of these unregulated, supposed dietary aids contain prescription drugs as part of their makeup, researchers wrote in an article published in the journal JAMA Network Open.

“Potentially harmful active pharmaceuticals continue to be identified in over-the-counter dietary supplements,” they wrote.

Looking at a period between 2007 and 2016, researchers analyzed supplements tainted with pharmaceuticals. In those years, they found that one in five dietary supplements contained more than one drug ingredient. During that period, 776 supplements marketed for muscle building, sexual enhancement, or weight loss were found to contain prescription drugs, such as the stimulant ephedrine, anabolic steroids, and selective serotonin reuptake inhibitors (SSRIs) commonly prescribed to treat anxiety and depression, as well as the active ingredients in erectile dysfunction drugs Viagra and Cialis, to name a few.

That isn’t a minor complication. These types of contaminations can have severe or even fatal implications for patients living with conditions such as heart disease or high cholesterol, which require medical oversight to stay healthy. Pop a pill that contains a drug that lowers your blood pressure, and if you happen to suffer from low blood pressure already, the consequences of this lack of oversight could be dire. Multiply that across most major types of managed conditions, and you can start to understand the severity of what researchers uncovered.

What’s possibly more alarming about the study, researchers say that even though these compromised supplements were submitted to the agency, the FDA often didn’t recall the tainted products, allowing them to remain on the market—and many are still on the market now.

In a commentary accompanying the article, Harvard Medical School professor and general internist Dr. Pieter A. Cohen chastised the FDA for a “dereliction of duty” as the agency responsible for regulating and ensuring the safety of consumer dietary supplements such as vitamins, minerals, probiotics, amino acids, and enzymes.

“While the FDA does not assess the safety of supplements prior to market, the agency is tasked with identifying and removing adulterated and hazardous supplements from the marketplace,” he wrote. “The FDA didn’t even bother to recall more than half of the potentially hazardous supplements.”

Dietary supplements are big business, a $35 billion industry in the United States alone. There are more than 90,000 vitamin and mineral supplements on the market, according to an article in JAMA, the Journal of the American Medical Association.

At least 52% of American adults take at least one dietary supplement every day, and 10% take at least four. Vitamins and minerals are the most popular supplement types, many with benefits advertised to maintain health and prevent disease. It remains unclear how effective these supplements, such as Vitamin D, the subject of a recent study, are to an individual’s long-term health.

About the Author
By Brittany Shoot
See full bioRight Arrow Button Icon

Latest in

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in

Alexander Gabrovsky
Successlifestyle
To unwind from his 12-hour shifts, this doctor splits his year between Kentucky and Venice—he pulls into his $438K apartment by boat
By Emma BurleighMarch 22, 2026
18 minutes ago
InvestingMark Cuban
Mark Cuban bought a $25 million mansion sight unseen — and got it for 50% off. His secret? ‘The best guaranteed return on investment’
By Sydney LakeMarch 22, 2026
1 hour ago
AIthe future of work
AI may be helping more people start their own businesses, but without many employees
By Marco Quiroz-GutierrezMarch 22, 2026
1 hour ago
Stressed rich man at desk
SuccessWealth
The K-shaped economy has left many six-figure earners ‘on thin ice’ as housing costs, lifestyle creep, and the job market put them at risk
By Emma BurleighMarch 22, 2026
1 hour ago
Donald Trump, standing behind a podium, frowns and points a finger upward.
Economygas prices
‘Almost exactly offsetting the boost’: Higher gasoline prices this year could wipe out tax refunds from Trump’s One Big Beautiful Bill Act
By Sasha RogelbergMarch 22, 2026
2 hours ago
AIFinance
Meet the CFO who turned Adobe’s finance department into an AI lab
By Sheryl EstradaMarch 22, 2026
2 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.